Synopsys Inc
Sentinellis Health Score
6.3/10
$94.6B
$7.1B
75.6x
AI Summary
Synopsys sells software tools that chip designers use to create, test, and verify semiconductors before manufacturing. Their products include design automation software, verification tools, FPGA design products, and pre-verified intellectual property (IP) blocks that accelerate chip development. The recent Ansys acquisition adds simulation and analysis capabilities, allowing Synopsys to serve customers across the full product development lifecycle from chip design to system-level engineering.
Synopsys is a $94.6 billion semiconductor design software company that provides chip design, verification, and IP solutions to the electronics industry [Yahoo Finance]. The company just completed a transformational acquisition of Ansys, which expanded its addressable market by 63% to $31 billion and drove Q1 FY26 revenue up 65% year-over-year [Simply Wall St]. With 28,000 employees and strong positions in AI-driven chip design tools, Synopsys is a critical enabler of the semiconductor ecosystem [Yahoo Finance].
Strong revenue growth and solid margins, but elevated debt from the Ansys acquisition and a stretched valuation create near-term financial pressure.
Recent News
A Look At Synopsys (SNPS) Valuation After Strong Q1 FY26 Results And Ansys Acquisition
Simply Wall St· 2026-05-19PRGS or SNPS: Which Is the Better Value Stock Right Now?
Yahoo Finance· 2026-05-19Synopsys (SNPS) Registers a Bigger Fall Than the Market: Important Facts to Note
Yahoo Finance· 2026-05-15Synopsys Price Prediction: The AI Play With Big Upside This Year
Yahoo Finance· 2026-05-15
Risk Analysis
Opportunities
Full Financials
Executive Team
Unlock the full Synopsys Inc analysis
Create a free account to access the complete AI-generated report with inline citations.
- Risks, opportunities, and red flags with sources
- 100+ financial metrics with charts and benchmarks
- Full news summaries with source links
- Executive team and compensation details
- PDF export for offline use
Other companies you might find interesting
Same sector (Technology) or comparable health.